Business StrategyBy scaling its Medical business and sharpening its focus within Passenger, the company has dramatically improved its earnings power.
Financial PerformanceBlade has dramatically improved its earnings power from an EBITDA burn of ($26M) in FY22 to breakeven in FY24 and $10M+ in FY25.
Market PositionBlade is taking market share from legacy sub-scale service providers, while longer flights and an expanded pool of donor organs via technological innovation drive volume growth.